NCT01533298View on ClinicalTrials.gov

A Safety, Efficacy Study of CombiflexOmega Peri Versus SmofKabiven Peripheral in Patients With Parenteral Nutrition

PHASE3CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions

Parent

Interventions

DRUG

CombiflexOmega peri

intravenously over 3 days infusion

DRUG

SmofKabiven peripheral

intravenously over 3 days infusion

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seoul

Sponsors

Lead Sponsor

JW Life Science

All Listed Sponsors

lead

JW Life Science

INDUSTRY